The European Commission has agreed an accelerated delivery of the BioNTech-Pfizer Covid-19 vaccine, with 10 million doses for the second quarter of the year.
The doses would be drawn forward from the option of 100 million doses in the second BioNTech-Pfizer contract, foreseen for Quarter 3 and Quarter 4 of 2021.
Today's proposal by the Commission needs to be approved by the member states in the Joint Steering Board. Commission President Ursula von der Leyen said she was aware how critical Quarter 2 is for the roll-out of the vaccination strategies in the member states. "These accelerated 10 million doses will bring the total doses of BioNTech-Pfizer in Quarter 2 up to over 200 million.